P3 Health Partners Inc (NASDAQ:PIII)’s traded shares stood at 0.47 million during the last session, with the company’s beta value hitting 1.16. At the close of trading, the stock’s price was $0.49, to imply a decrease of -1.36% or -$0.01 in intraday trading. The PIII share’s 52-week high remains $2.85, putting it -481.63% down since that peak but still an impressive 18.37% since price per share fell to its 52-week low of $0.40. The company has a valuation of $79.78M, with an average of 0.62 million shares in intraday trading volume over the past 10 days and average of 338.59K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for P3 Health Partners Inc (PIII), translating to a mean rating of 1.80. Of 2 analyst(s) looking at the stock, 0 analyst(s) give PIII a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
P3 Health Partners Inc (NASDAQ:PIII) trade information
After registering a -1.36% downside in the last session, P3 Health Partners Inc (PIII) has traded red over the past five days. The 5-day price performance for the stock is 7.22%, and -16.41% over 30 days. With these gigs, the year-to-date price performance is -65.02%. Short interest in P3 Health Partners Inc (NASDAQ:PIII) saw shorts transact 1.25 million shares and set a 4.24 days time to cover.
P3 Health Partners Inc (PIII) estimates and forecasts
Looking at statistics comparing P3 Health Partners Inc share performance against respective industry, we note that the company has outperformed competitors. P3 Health Partners Inc (PIII) shares are -30.21% down over the last 6 months, with its year-to-date growth rate higher than industry average at 63.49% against 21.10%. Revenue is forecast to grow 66.70% this quarter before jumping 81.80% for the next one. The rating firms project that company’s revenue will grow 20.40% compared to the previous financial year.
Revenue forecast for the current quarter as set by 5 analysts is 364.45M. Meanwhile, for the current quarter, a total of 5 analyst(s) estimate revenue growth to 392.11M.
PIII Dividends
P3 Health Partners Inc has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
P3 Health Partners Inc insiders hold 23.36% of total outstanding shares, with institutional holders owning 23.65% of the shares at 30.86% float percentage. In total, 23.65% institutions holds shares in the company, led by ALYESKA INVESTMENT GROUP, L.P.. As of 2024-06-30, the company held over 15.95 million shares (or 13.4152% of shares), all amounting to roughly $7.18 million.
The next major institution holding the largest number of shares is ARMISTICE CAPITAL, LLC with 7.9 million shares, or about 6.645% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.56 million.
